J. Virol., Dec 1996, 8285-8300, Vol 70, No. 12
Copyright © 1996, American Society for Microbiology

The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses

S Bour and K Strebel
Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892-0460, USA. sb32i@nih.gov

We have recently shown that the envelope glycoprotein of the ROD10 isolate of human immunodeficiency virus type 2 (HIV-2) has the ability to positively regulate HIV-2 viral particle release. The activity provided by the ROD10 Env was remarkably similar to that of the HIV-1 Vpu protein, thus raising the possibility that the two proteins act in a related fashion. We now show that the ROD10 Env can functionally replace Vpu to enhance the rate of HIV-1 particle release. When provided in trans, both Vpu and the ROD10 Env restored wild-type levels of particle release in a Vpu-deficient mutant of the NL4-3 molecular clone with indistinguishable efficiencies. This effect was independent of the presence of the HIV-1 envelope protein. The ROD10 Env also enhanced HIV-1 particle release in the context of HIV-2 chimeric viruses containing the HIV-1 gag-pol, indicating a lack of need for additional HIV-1 products in this process. In addition, we show for the first time that HIV-1 Vpu, as well as ROD10 Env, has the ability to enhance simian immunodeficiency virus (SIV) particle release. The effects of Vpu and ROD10 Env on SIV particle release were indistinguishable and were observed in the context of full-length SIVmac239 and simian-human immunodeficiency virus chimeras. These results further demonstrate that ROD10 Env can functionally complement Vpu with respect to virus release. In contrast, we found no evidence of a destabilizing activity of ROD10 Env on the CD4 molecule. HIV-1 and HIV-2 thus appear to have evolved genetically distinct but functionally similar strategies to resolve the common problem of efficient release of progeny virus from infected cells.

This article has been cited by other articles:

• Richards, K. H., Clapham, P. R. (2007). Effects of vpu start-codon mutations on human immunodeficiency virus type 1 replication in macrophages. J. Gen. Virol. 88: 2780-2792 [Abstract] [Full Text]  
• Park, S. H., Opella, S. J. (2007). Conformational changes induced by a single amino acid substitution in the trans-membrane domain of Vpu: Implications for HIV-1 susceptibility to channel blocking drugs. Protein Sci. 16: 2205-2215 [Abstract] [Full Text]  
• Noble, B., Abada, P., Nunez-Iglesias, J., Cannon, P. M. (2006). Recruitment of the Adaptor Protein 2 Complex by the Human Immunodeficiency Virus Type 2 Envelope Protein Is Necessary for High Levels of Virus Release. J. Virol. 80: 2924-2932 [Abstract] [Full Text]  
• Dazza, M.-C., Ekwalanga, M., Nende, M., Shamamba, K. B., Bitshi, P., Paraskevis, D., Saragosti, S. (2005). Characterization of a Novel vpu-Harboring Simian Immunodeficiency Virus from a Dent's Mona Monkey (Cercopithecus mona denti). J. Virol. 79: 8560-8571 [Abstract] [Full Text]  
• Abada, P., Noble, B., Cannon, P. M. (2005). Functional Domains within the Human Immunodeficiency Virus Type 2 Envelope Protein Required To Enhance Virus Production. J. Virol. 79: 3627-3638 [Abstract] [Full Text]  
• Akari, H., Fujita, M., Kao, S., Khan, M. A., Shehu-Xhilaga, M., Adachi, A., Strebel, K. (2004). High Level Expression of Human Immunodeficiency Virus Type-1 Vif Inhibits Viral Infectivity by Modulating Proteolytic Processing of the Gag Precursor at the p2/Nucleocapsid Processing Site. J. Biol. Chem. 279: 12355-12362 [Abstract] [Full Text]  
• Varthakavi, V., Smith, R. M., Bour, S. P., Strebel, K., Spearman, P. (2003). Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production. Proc. Natl. Acad. Sci. USA 100: 15154-15159 [Abstract] [Full Text]  
• Ma, C., Marassi, F. M., Jones, D. H., Straus, S. K., Bour, S., Strebel, K., Schubert, U., Oblatt-Montal, M., Montal, M., Opella, S. J. (2002). Expression, purification, and activities of full-length and truncated versions of the integral membrane protein Vpu from HIV-1. Protein Sci. 11: 546-557 [Abstract] [Full Text]  
• Akari, H., Bour, S., Kao, S., Adachi, A., Strebel, K. (2001). The Human Immunodeficiency Virus Type 1 Accessory Protein Vpu Induces Apoptosis by Suppressing the Nuclear Factor {kappa}B-dependent Expression of Antiapoptotic Factors. J. Exp. Med. 194: 1299-1312 [Abstract] [Full Text]  
• Deora, A., Ratner, L. (2001). Viral Protein U (Vpu)-Mediated Enhancement of Human Immunodeficiency Virus Type 1 Particle Release Depends on the Rate of Cellular Proliferation. J. Virol. 75: 6714-6718 [Abstract] [Full Text]  
• Akari, H., Arold, S., Fukumori, T., Okazaki, T., Strebel, K., Adachi, A. (2000). Nef-Induced Major Histocompatibility Complex Class I Down-Regulation Is Functionally Dissociated from Its Virion Incorporation, Enhancement of Viral Infectivity, and CD4 Down-Regulation. J. Virol. 74: 2907-2912 [Abstract] [Full Text]  
• Bour, S., Perrin, C., Strebel, K. (1999). Cell Surface CD4 Inhibits HIV-1 Particle Release by Interfering with Vpu Activity. J. Biol. Chem. 274: 33800-33806 [Abstract] [Full Text]  
• Schubert, U., Bour, S., Willey, R. L., Strebel, K. (1999). Regulation of Virus Release by the Macrophage-Tropic Human Immunodeficiency Virus Type 1 AD8 Isolate Is Redundant and Can Be Controlled by either Vpu or Env. J. Virol. 73: 887-896 [Abstract] [Full Text]  
• Bour, S. P., Aberham, C., Perrin, C., Strebel, K. (1999). Lack of Effect of Cytoplasmic Tail Truncations on Human Immunodeficiency Virus Type 2 ROD Env Particle Release Activity. J. Virol. 73: 778-782 [Abstract] [Full Text]  
• Paul, M., Mazumder, S., Raja, N., Jabbar, M. A. (1998). Mutational Analysis of the Human Immunodeficiency Virus Type 1 Vpu Transmembrane Domain That Promotes the Enhanced Release of Virus-Like Particles from the Plasma Membrane of Mammalian Cells. J. Virol. 72: 1270-1279 [Abstract] [Full Text]  
• Kim, V. N., Mitrophanous, K., Kingsman, S. M., Kingsman, A. J. (1998). Minimal Requirement for a Lentivirus Vector Based on Human Immunodeficiency Virus Type 1. J. Virol. 72: 811-816 [Abstract] [Full Text]  
• Bour, S., Perrin, C., Akari, H., Strebel, K. (2001). The Human Immunodeficiency Virus Type 1 Vpu Protein Inhibits NF-kappa B Activation by Interfering with beta TrCP-mediated Degradation of Ikappa B. J. Biol. Chem. 276: 15920-15928 [Abstract] [Full Text]